Sibah graduated with a PhD in Life Science from the University of Lausanne, where he validated a new wake-promoting compound (FDA & EMA approved) using a pharmacogenomics approach. He has over 10 years of postdoctoral experience in Neuroscience research (Surrey and Oxford Universities) ranging from biomarker development (for Sleep and Circadian rhythms) to studying the effects of light in brain and behaviour. After finishing his postdoctoral research at the Department of Pharmacology (University of Oxford), working on septo-hippocampal oscillations, he joined Neuro-Bio as Senior Neuroscientist. Sibah is now working on both biomarkers and therapeutic approaches to tackle neurodegeneration, using in vitro model of AD to screen novel compounds at the cellular level, and understand their mode of action.

View Sibah’s LinkedIn page

Anna has extensive experience in research spanning pharmaceutical, biotech and academic labs. She graduated with a PhD in Medical Sciences from the University of Aberdeen, in which she studied the role of retinoic acid in the pineal gland. She then gained postdoctoral experience in the Clinical Neurosciences department at the University of Oxford, where she studied the molecular mechanisms of the circadian clock through genomic, proteomic and imaging approaches. Anna joined Neuro-Bio in May 2022 and is currently conducting research into the biosynthesis of T14. This will inform the development of novel therapeutics targeting T14 for the treatment of Alzheimer’s disease.

View Anna’s LinkedIn page

Kashif received his PhD in Neuroscience from the University of Navarra, Spain. His thesis was focussed on short term synaptic plasticity (STP) and epilepsy. In 2016, he joined Department of Pharmacology at the University of Oxford as a Postdoctoral research fellow. He has more than 14 years of experience in Neuroscience research with expertise in the field of neurodevelopmental disorders, cortical circuit formation and neurodegeneration. He joined Neuro-Bio as Senior Scientist and he is using optical and electrophysiological techniques to screen and identify lead compounds with potential for Alzheimer’s therapy.

View Kashif’s LinkedIn page

Helen received her DPhil in Neuroscience from the University of Oxford in 2023, where she developed a mouse model of Antidepressant Discontinuation Syndrome. Previously, she graduated with an BA in Cell and Systems Biology and a MSc in Neuroscience from the University of Oxford, having gained experience in preclinical studies of neurodegeneration. Helen is a Senior Postdoctoral Scientist at Neuro-Bio and is currently working on establishing primary cell cultures to investigate the cellular mechanisms of Alzheimer’s disease, as well as coordinating the development of a novel mouse model of the condition.

View Helen’s LinkedIn page

Joanna is a third-year student of Neuroscience with Psychology at the University of Aberdeen, originally from Poland. She is interested in neurogenerative diseases and how they affect the human body and mind. For this reason, she is finding the opportunity to do her placement in Neuro-Bio very exciting. In her free time, she enjoys reading books and drawing. she is looking forward to her industrial placement as she believes it will broaden her mind, develop her as a person and a future scientist, and allow her to make new friends.

View Joanna’s LinkedIn page

Nikki is a second year Medical Sciences undergraduate at the University of Exeter. During the summer, she participated in a synthetic biology competition where she gained experience working in the lab and various synbio techniques. She has a keen interest in neuroscience, especially neurodegeneration and looks forward to starting her placement at Neuro-Bio where she hopes to learn new techniques and contribute to Neuro-Bio’s novel approach to Alzheimer’s research.

Cloe is a third-year physiology undergraduate at the University of Glasgow. She has a keen interest in the mechanisms that trigger neurodegenerative diseases and potential novel treatments. Having experience with molecular techniques, such as PCR, Cloe is really looking forward to her placement year at Neuro-Bio, where she can further enhance her lab technique. She also hopes to gain a greater understanding of AD pathogenesis, make new connections, and prepare herself for a career in research.